HuGE Literature Finder
Records
1
-
30
| Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers. NPJ breast cancer 2021 Nov 7 (1): 143. Alblihy Adel, Shoqafi Ahmed, Toss Michael S, Algethami Mashael, Harris Anna E, Jeyapalan Jennie N, Abdel-Fatah Tarek, Servante Juliette, Chan Stephen Y T, Green Andrew, Mongan Nigel P, Rakha Emad A, Madhusudan Srinivas |
| Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. NPJ breast cancer 2021 Jun 7 (1): 76. Li Na, Lim Belle W X, Thompson Ella R, McInerny Simone, Zethoven Magnus, Cheasley Dane, Rowley Simone M, Wong-Brown Michelle W, Devereux Lisa, Gorringe Kylie L, Sloan Erica K, Trainer Alison, Scott Rodney J, James Paul A, Campbell Ian |
| Extended gene panel testing in lobular breast cancer. Familial cancer 2021 Mar . van Veen Elke M, Evans D Gareth, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Woodward Emma R, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam |
| Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. Oncotarget 2021 Mar 12 (7): 686-697. Barakeh Duna H, Aljelaify Rasha, Bashawri Yara, Almutairi Amal, Alqubaishi Fatimah, Alnamnakani Mohammed, Almubarak Latifa, Al Naeem Abdulrahman, Almushawah Fatema, Alrashed May, Abedalthagafi Mal |
| Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk. Annals of translational medicine 2020 Nov 8 (21): 1417. Lang Guan-Tian, Shi Jin-Xiu, Huang Liang, Cao A-Yong, Zhang Chen-Hui, Song Chuan-Gui, Zhuang Zhi-Gang, Hu Xin, Huang Wei, Shao Zhi-Mi |
| Gene Panel Testing in Hereditary Breast Cancer. Archives of Iranian medicine 2020 Mar 23 (3): 155-162. Rostami Parvin, Zendehdel Kazem, Shirkoohi Reza, Ebrahimi Elmira, Ataei Mitra, Imanian Hashem, Najmabadi Hossein, Akbari Mohammad Reza, Sanati Mohammad Hosse |
| Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients. Frontiers in genetics 2020 11 552971. Mighri Najah, Hamdi Yosr, Boujemaa Maroua, Othman Houcemeddine, Ben Nasr Sonia, El Benna Houda, Mejri Nesrine, Labidi Soumaya, Ayari Jihen, Jaidene Olfa, Bouaziz Hanen, Ben Rekaya Mariem, M'rad Ridha, Haddaoui Abderrazek, Rahal Khaled, Boussen Hamouda, Boubaker Samir, Abdelhak Son |
| Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
| Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast cancer research and treatment 2019 Sep . Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, Ghilli M, Rossetti E, Roncella M, Congregati C, Bonci F, Naccarato A G, Palli D, Caligo M |
| RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients. International journal of cancer 2018 Oct 143 (8): 1935-1942. Fan Cong, Zhang Juan, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
| Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan. Breast cancer (Tokyo, Japan) 2018 May 25 (3): 350-355. Khan Rabbia Tariq, Siddique Ayesha, Shahid Naeem, Khokher Samina, Fatima War |
| High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
| Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families. Cancer medicine 2018 01 7 (1): 46-55. Coppa Anna, Nicolussi Arianna, D'Inzeo Sonia, Capalbo Carlo, Belardinilli Francesca, Colicchia Valeria, Petroni Marialaura, Zani Massimo, Ferraro Sergio, Rinaldi Christian, Buffone Amelia, Bartolazzi Armando, Screpanti Isabella, Ottini Laura, Giannini Giusep |
| Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
| Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer. Breast care (Basel, Switzerland) 2017 May 12 (2): 114-116. Sharma Bhai Pratibha, Sharma Deepak, Saxena Renu, Verma Ishwar |
| Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway. International journal of molecular sciences 2017 Feb 18 (2): . van der Merwe Nicole, Peeters Armand V, Pienaar Fredrieka M, Bezuidenhout Juanita, van Rensburg Susan J, Kotze Maritha |
| Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis 2017 05 38 (5): 511-518. Han Mi-Ryung, Zheng Wei, Cai Qiuyin, Gao Yu-Tang, Zheng Ying, Bolla Manjeet K, Michailidou Kyriaki, Dennis Joe, Wang Qin, Dunning Alison M, Brennan Paul, Chen Shou-Tung, Choi Ji-Yeob, Hartman Mikael, Ito Hidemi, Lophatananon Artitaya, Matsuo Keitaro, Miao Hui, Muir Kenneth, Sangrajrang Suleeporn, Shen Chen-Yang, Teo Soo Hwang, Tseng Chiu-Chen, Wu Anna H, Yip Cheng Har, Kang Daehee, Xiang Yong-Bing, Easton Douglas F, Shu Xiao-Ou, Long Jiro |
| Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. Breast cancer research and treatment 2017 01 161 (1): 95-102. Kim Haeyoung, Cho Dae-Yeon, Choi Doo Ho, Oh Mijin, Shin Inkyung, Park Won, Huh Seung Jae, Nam Seok Jin, Lee Jeong Eon, Kim Seok W |
| The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels. PloS one 2017 12 (9): e0185615. Sung Pi-Lin, Wen Kuo-Chang, Chen Yi-Jen, Chao Ta-Chung, Tsai Yi-Fang, Tseng Ling-Ming, Qiu Jian-Tai Timothy, Chao Kuan-Chong, Wu Hua-Hsi, Chuang Chi-Mu, Wang Peng-Hui, Huang Chi-Ying |
| Whole-exome sequencing of Finnish hereditary breast cancer families. European journal of human genetics : EJHG 2016 Oct . Määttä Kirsi, Rantapero Tommi, Lindström Anna, Nykter Matti, Kankuri-Tammilehto Minna, Laasanen Satu-Leena, Schleutker Johan |
| Reevaluation of RINT1 as a breast cancer predisposition gene. Breast cancer research and treatment 2016 Sep 159 (2): 385-92. Li Na, Thompson Ella R, Rowley Simone M, McInerny Simone, Devereux Lisa, Goode David, Investigators LifePool, Wong-Brown Michelle W, Scott Rodney J, Trainer Alison H, Gorringe Kylie L, James Paul A, Campbell Ian |
| Germline mutations of the DNA repair pathways in uterine serous carcinoma. Gynecologic oncology 2016 Apr 141 (1): 101-7. Frimer Marina, Levano Kelly S, Rodriguez-Gabin Alicia, Wang Yanhua, Goldberg Gary L, Horwitz Susan Band, Hou June |
| Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget 2016 Jan . Lin Po-Han, Kuo Wen-Hung, Huang Ai-Chu, Lu Yen-Shen, Lin Ching-Hung, Kuo Sung-Hsin, Wang Ming-Yang, Liu Chun-Yu, Cheng Fiona Tsui-Fen, Yeh Ming-Hsin, Li Huei-Ying, Yang Yu-Hsuan, Hsu Yu-Hua, Fan Sheng-Chih, Li Long-Yuan, Yu Sung-Liang, Chang King-Jen, Chen Pei-Lung, Ni Yen-Hsuan, Huang Chiun-She |
| Multigene testing of moderate-risk genes: be mindful of the missense. Journal of medical genetics 2016 06 53 (6): 366-76. Young E L, Feng B J, Stark A W, Damiola F, Durand G, Forey N, Francy T C, Gammon A, Kohlmann W K, Kaphingst K A, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette A M, Pertesi M, Robinot N, Rosenthal J S, Vallee M, Voegele C, Hopper J L, Southey M C, Andrulis I L, John E M, Hashibe M, Gertz J, , Le Calvez-Kelm F, Lesueur F, Goldgar D E, Tavtigian S |
| Detection of novel germline mutations for breast cancer in non-BRCA1/2 families. The FEBS journal 2015 Sep 282 (17): 3424-37. Aloraifi Fatima, McDevitt Trudi, Martiniano Rui, McGreevy Jonah, McLaughlin Russell, Egan Chris M, Cody Nuala, Meany Marie, Kenny Elaine, Green Andrew J, Bradley Daniel G, Geraghty James G, Bracken Adrian |
| Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies. Cancer genetics 2015 Sep 208 (9): 455-63. Aloraifi Fatima, McCartan Damian, McDevitt Trudi, Green Andrew J, Bracken Adrian, Geraghty Jam |
| A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer. Anticancer research 2015 May 35 (5): 2601-10. Amemiya Yutaka, Bacopulos Stephanie, Al-Shawarby Mohamed, Al-Tamimi Dalal, Naser Walid, Ahmed Ayesha, Khalifa Mahmoud, Slodkowska Elzbieta, Seth Ar |
| Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC medical genetics 2014 15 (1): 55. Silva Felipe C, Lisboa Bianca Cg, Figueiredo Marcia Cp, Torrezan Giovana T, Santos Erika Mm, Krepischi Ana C, Rossi Benedito M, Achatz Maria I, Carraro Dirce |
| Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
| Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients. Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: